Skip to main content Back to Top
Advertisement

10/1/2019

Olanzapine Intramuscular Injection

Products Affected - Description

    • Olanzapine intramuscular injection, American Regent, 10 mg, vial, 1 count, NDC 00517-0955-01
    • Olanzapine intramuscular injection, Sandoz, 10 mg, vial, 1 count, NDC 00781-3159-72

Reason for the Shortage

    • American Regent did not provide a reason for the shortage.
    • Lilly has Zyprexa intramuscular injection available.
    • Sandoz did not provide a reason for the shortage.

Available Products

    • Zyprexa intramuscular injection, Lilly USA, LLC, 10 mg, vial, 1 count, NDC 00002-7597-01

Estimated Resupply Dates

    • American Regent has olanzapine 10 mg vials for intramuscular injection available in limited supply.
    • Sandoz has olanzapine 10 mg vials on back order and the company estimates a release date of mid-October 2019.

Updated

Updated October 1, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 12, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins